{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:41:49Z","timestamp":1784335309517,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T00:00:00Z","timestamp":1436745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T00:00:00Z","timestamp":1436745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/bmt.2015.163","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T13:41:18Z","timestamp":1436794878000},"page":"1473-1475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dynamic change of glycemic status during the early phase after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"50","author":[{"given":"S","family":"Fuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yakushijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-W","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,13]]},"reference":[{"key":"BFbmt2015163_CR1","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/01.tp.0000296482.50994.1c","volume":"84","author":"S Fuji","year":"2007","unstructured":"Fuji S, Kim SW, Mori S, Fukuda T, Kamiya S, Yamasaki S et al. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation 2007; 84: 814\u2013820.","journal-title":"Transplantation"},{"key":"BFbmt2015163_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10753-012-9533-7","volume":"36","author":"E Gebremedhin","year":"2013","unstructured":"Gebremedhin E, Behrendt CE, Nakamura R, Parker P, Salehian B . Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease. Inflammation 2013; 36: 177\u2013185.","journal-title":"Inflammation"},{"key":"BFbmt2015163_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/bmt.2008.431","volume":"44","author":"S Fuji","year":"2009","unstructured":"Fuji S, Kim SW, Mori S, Kamiya S, Yoshimura K, Yokoyama H et al. Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study. Bone Marrow Transplant 2009; 44: 105\u2013111.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015163_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/MCO.0b013e32833571f4","volume":"13","author":"C Scurlock","year":"2010","unstructured":"Scurlock C, Raikhelkar J, Mechanick JI . Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR)\u2014a review of recent literature. Curr Opin Clin Nutr Metab Care 2010; 13: 211\u2013214.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"BFbmt2015163_CR5","doi-asserted-by":"publisher","first-page":"vi8","DOI":"10.1093\/ndt\/gfh1063","volume":"19","author":"JP van Hooff","year":"2004","unstructured":"van Hooff JP, Christiaans MH, van Duijnhoven EM . Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant 2004; 19: vi8\u2013vi12.","journal-title":"Nephrol Dial Transplant"},{"key":"BFbmt2015163_CR6","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR . Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487\u20131495.","journal-title":"Diabetes Care"},{"key":"BFbmt2015163_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1164\/rccm.201002-0190OC","volume":"182","author":"MG Jeschke","year":"2010","unstructured":"Jeschke MG, Kulp GA, Kraft R, Finnerty CC, Mlcak R, Lee JO et al. Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med 2010; 182: 351\u2013359.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFbmt2015163_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/0148607108316195","volume":"32","author":"F Saberi","year":"2008","unstructured":"Saberi F, Heyland D, Lam M, Rapson D, Jeejeebhoy K . Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. JPEN J Parenter Enteral Nutr 2008; 32: 227\u2013235.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"BFbmt2015163_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013; 48: 452\u2013458.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015163_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/cc9100","volume":"14","author":"MR Losser","year":"2010","unstructured":"Losser MR, Damoisel C, Payen D . Bench-to-bedside review: glucose and stress conditions in the intensive care unit. Crit Care 2010; 14: 231.","journal-title":"Crit Care"},{"key":"BFbmt2015163_CR11","first-page":"710","volume":"89","author":"M Remberger","year":"2004","unstructured":"Remberger M, Sundberg B . Cytokine production during myeloablative and reduced intensity therapy before allogeneic stem cell transplantation. Haematologica 2004; 89: 710\u2013716.","journal-title":"Haematologica"},{"key":"BFbmt2015163_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/sj.bmt.1705295","volume":"37","author":"J Andersen","year":"2006","unstructured":"Andersen J, Heilmann C, Jacobsen N, Nielsen C, Bendtzen K, Muller K . Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 37: 635\u2013640.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015163_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/cs0990321","volume":"99","author":"C Chambrier","year":"2000","unstructured":"Chambrier C, Laville M, Rhzioual Berrada K, Odeon M, Bouletreau P, Beylot M . Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci (Lond) 2000; 99: 321\u2013328.","journal-title":"Clin Sci (Lond)"},{"key":"BFbmt2015163_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.bbmt.2008.02.008","volume":"14","author":"S Fuji","year":"2008","unstructured":"Fuji S, Kim SW, Fukuda T, Mori S, Yamasaki S, Morita-Hoshi Y et al. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 510\u2013517.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015163_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/bmt.2009.154","volume":"45","author":"S Fuji","year":"2010","unstructured":"Fuji S, Kim SW, Mori S, Furuta K, Tanosaki R, Heike Y et al. Decreased insulin secretion in patients receiving tacrolimus as GVHD prophylaxis after allogeneic hematopoietic SCT. Bone Marrow Transplant 2010; 45: 405\u2013406.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2015163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:18:38Z","timestamp":1648059518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2015163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,13]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFbmt2015163"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.163","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,13]]},"assertion":[{"value":"13 July 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}